1. thisiswheremymon
2. maclia
3. asal3986
4. hoffman4568john
5. hiphopmusic
1.maclia 01/26/2018
Bigger than most are thinking
2.hoffman4568john 07/06/2018
Nomura Instinet sets PT at $420
3.thisiswheremymon 01/25/2018
Biogen is acquiring KPT-350 and other assets targeting certain neurological conditions, including amyotrophi…
4.maclia 01/25/2018
Misses EPS estimates by $0.19. Beats on revenues.
5.hoffman4568john 07/24/2018
Beats EPS estimates by $0.71 and beats on revenues
6.maclia 04/22/2018
Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases
7.hiphopmusic 07/02/2018
Mizuho Securities sets PT at $423
8.hiphopmusic 06/28/2018
Biogen Exercises Option to Increase Ownership in Samsung Bioepis
9.thisiswheremymon 01/24/2018
Canaccord Genuity raises PT to $350 from $340
10.thisiswheremymon 06/05/2018
Phase II Clinical Study Of Elenbecestat Demonstrates Safety And Tolerability In MCI And Mild To Moderate Alzheimer's Disease At 18-Months
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW